OCUPHARM DIAGNOSTICS Trademark

Trademark Overview


On Wednesday, January 15, 2025, a trademark application was filed for OCUPHARM DIAGNOSTICS with the United States Patent and Trademark Office. The USPTO has given the OCUPHARM DIAGNOSTICS trademark a serial number of 98964588. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, July 7, 2025. This trademark is owned by Ocupharm Diagnostics, SL. The OCUPHARM DIAGNOSTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Ocular pharmaceuticals; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists

Chemical analysis; Pharmaceutical research and development; Scientific investigations for medical purposes; Scientific research consulting
ocupharm diagnostics

General Information


Serial Number98964588
Word MarkOCUPHARM DIAGNOSTICS
Filing DateWednesday, January 15, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, July 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a curved lines design inside of which appears a partial circle. Below the design appears the word OCUPHARM in stylized letters below of which appears the word DIAGNOSTICS in stylized letters.
Goods and ServicesOcular pharmaceuticals; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"DIAGNOSTICS"
Goods and ServicesChemical analysis; Pharmaceutical research and development; Scientific investigations for medical purposes; Scientific research consulting

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 15, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 15, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOcupharm Diagnostics, SL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMadrid 28002
ES

Trademark Events


Event DateEvent Description
Wednesday, January 15, 2025NEW APPLICATION ENTERED
Thursday, May 8, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 8, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 16, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, June 24, 2025NON-FINAL ACTION E-MAILED
Thursday, May 8, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 24, 2025ASSIGNED TO EXAMINER
Monday, July 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 24, 2025NON-FINAL ACTION WRITTEN
Tuesday, June 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED